US FDA will be irrelevant if they attempt that; Health Canada won't be messing around. ANVISA / Brazil may have issues with political pressure, but popular pressure can easily overcome that, if Brazilians are aware..

But to answer your question, slow playing the protocol approval would be the easiest, at this stage.